GENEMATRIX INC. is a Korea-based biotechnology company. The Company mainly develops restriction fragment mass polymorphisms (RFMP) clinical diagnostic systems, RFMP molecular markers, human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) theranostics systems, molecular diagnostic platforms, and systems for microorganism identification. The Company acquired 53.77% of HBI Co., Ltd., engaged in pharmaceutical manufacturing business, on February 18, 2011.